4//SEC Filing
SPECTRUM PHARMACEUTICALS INC 4
Accession 0001209191-14-044851
CIK 0000831547operating
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 8:14 PM ET
Size
9.3 KB
Accession
0001209191-14-044851
Insider Transaction Report
Form 4
LENAZ LUIGI MD
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-06-27+20,000→ 20,000 totalExercise: $7.94Exp: 2024-06-27→ Common Stock (20,000 underlying) - Tax Payment
Common Stock, $0.001 par value
2014-06-27$7.94/sh−625$4,963→ 47,202 total - Award
Common Stock, $0.001 par value
2014-06-27+10,000→ 47,827 total
Footnotes (3)
- [F1]25% of the restricted shares vested on June 27, 2014. The remaining restricted shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years.
- [F2]Represents restricted shares withheld by Spectrum to satisfy the Reporting Person's tax withholding obligations. The shares have not been sold by the Reporting Person or by Spectrum. The shares have been cancelled by the transfer agent and returned to Spectrum's authorized and unissued share pool.
- [F3]25% of the option shares vested on June 27, 2014. The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years.
Documents
Issuer
SPECTRUM PHARMACEUTICALS INC
CIK 0000831547
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000831547
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 8:14 PM ET
- Size
- 9.3 KB